Categories: NewsPharmaceutical

Veeva to Host Virtual Investor Day on Nov. 7, 2024

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, November 7, 2024. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT.

Veeva will broadcast the presentations live on the company’s investor relations website, ir.veeva.com, where a link to the archived webcast will also be available after the event.

Event:              Veeva Systems 2024 Investor Day

Date:                Thursday, November 7, 2024

Time:               1:30 p.m. PT (4:30 p.m. ET)

Online event registration can be found on the company’s investor relations website or directly at this link.

Webcast:          ir.veeva.com

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings, and public conference calls and webcasts.

Investor Relations Contact:

Media Contact:


Gunnar Hansen
Veeva Systems Inc.
267-460-5839
ir@veeva.com


Maria Scurry
Veeva Systems Inc.
781-366-7617
pr@veeva.com

 

View original content:https://www.prnewswire.com/news-releases/veeva-to-host-virtual-investor-day-on-nov-7-2024-302276907.html

SOURCE Veeva Systems

Staff

Recent Posts

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities

LONDON, UK / ACCESS Newswire / January 28, 2026 / THE INFORMATION CONTAINED WITHIN THIS…

40 minutes ago

Invitation to Cosmo’s Full Year 2025 Financial Results Webcast on 9 March 2026

Dublin, Ireland--(Newsfile Corp. - January 28, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

2 hours ago

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the…

4 hours ago

REJUVA FRESH® Unveils Three Cutting-Edge Technologies to Empower Providers with a Competitive Edge in 2026

ELLSWORTH, Maine, Jan. 27, 2026 /PRNewswire/ -- At the start of 2026, forward-thinking providers are…

10 hours ago

Revance Executives to Present at IMCAS World Congress 2026

Jeff Bedard and Conor Gallagher to share insights on aesthetic and therapeutic innovationNASHVILLE, Tenn., Jan.…

10 hours ago